Host cells containing multiple integrating vectors

Details for Australian Patent Application No. 2001271614 (hide)

Owner Gala Design, Inc.

Inventors Miller, Linda U.; Bremel, Robert D.; Bleck, Gregory T

Agent Spruson & Ferguson

Pub. Number AU-B-2001271614

PCT Pub. Number WO02/02738

Priority 07/897511 29.06.01 US; 60/215925 03.07.00 US

Filing date 29 June 2001

Wipo publication date 14 January 2002

Acceptance publication date 31 May 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C07K 14/02 (2006.01) Peptides having more than 20 amino acids

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

C12N 15/867 (2006.01) Mutation or genetic engineering - Retroviral vectors

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

Event Publications

13 March 2003 Amendment Made

  The nature of the amendment is: Add 2nd priority document US 07/897511 filed 29 June 2001

20 May 2004 Amendment Made

  The nature of the amendment is: Delete the co-inventor York, Donna. 2002

31 May 2007 Application Accepted

  Published as AU-B-2001271614

27 September 2007 Standard Patent Sealed

3 March 2011 Assignment Registered

  Gala Design, Inc. The patent has been assigned to Catalent Pharma Solutions, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001271615

2001271613